HORIZON THERAPEUTICS
Horizon Therapeutics is a specialty and generic drug manufacturing company. The company is focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: the orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division.
HORIZON THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Manufacturing
Founded:
2008-01-01
Status:
Active
Total Funding:
2.7 B USD
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
NTpharma
NTpharma provides GMP production of nanovaccines and biopharmaceuticals containing carbohydrate binders.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-01 | Viela Bio | Viela Bio acquired by Horizon Therapeutics | 3.05 B USD |
| 2020-04-02 | Curzion Pharmaceuticals | Curzion Pharmaceuticals acquired by Horizon Therapeutics | N/A |
| 2016-10-25 | Raptor Pharmaceuticals | Raptor Pharmaceuticals acquired by Horizon Therapeutics | N/A |
| 2015-05-07 | Hyperion Therapeutics | Hyperion Therapeutics acquired by Horizon Therapeutics | N/A |
| 2014-09-19 | Vidara Therapeutics | Vidara Therapeutics acquired by Horizon Therapeutics | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Horizon Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Horizon Therapeutics
Kreos Capital
Kreos Capital investment in Post-IPO Debt - Horizon Therapeutics